Media Summary: Nov.12 -- Joy Fitzgerald, Vice President, Chief Diversity & Inclusion Officer, The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ... Bloomberg Intelligence's Sam Fazeli discusses

Eli Lilly Bcg Atlassian Execs - Detailed Analysis & Overview

Nov.12 -- Joy Fitzgerald, Vice President, Chief Diversity & Inclusion Officer, The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ... Bloomberg Intelligence's Sam Fazeli discusses Nvidia plans to invest $1 billion over five years in a new laboratory with Geoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to discuss the company's ... CNBC's Jim Cramer delivers his daily Mad Dash. For access to live and exclusive video from CNBC subscribe to CNBC PRO: ...

Photo Gallery

Eli Lilly, BCG, Atlassian Execs on Leadership, Employee Mental Health
Eli Lilly inks $2.8B AI drug discovery deal
Eli Lilly CFO on $1 Billion AI Drug Lab Investment
Why Eli Lilly Is Buying Centessa for $7.8 Billion
Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing
Alphabet Names Eli Lilly Executive Ashkenazi as CFO
Nvidia Partners With Eli Lilly on AI Drug Laboratory
Eli Lilly CFO Lucas Montrace Explains What Drove 56% Year over Year Revenue Beat
Eli Lilly CFO resigns over 'inappropriate' communication
BofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesity
Cramer’s Mad Dash: Eli Lilly
Eli Lilly CEO: Deep mistrust with communities of color needs to be addressed
View Detailed Profile
Eli Lilly, BCG, Atlassian Execs on Leadership, Employee Mental Health

Eli Lilly, BCG, Atlassian Execs on Leadership, Employee Mental Health

Nov.12 -- Joy Fitzgerald, Vice President, Chief Diversity & Inclusion Officer,

Eli Lilly inks $2.8B AI drug discovery deal

Eli Lilly inks $2.8B AI drug discovery deal

The pharmaceutical company is expanding its AI-driven drug development efforts through an agreement with Hong Kong-based ...

Eli Lilly CFO on $1 Billion AI Drug Lab Investment

Eli Lilly CFO on $1 Billion AI Drug Lab Investment

Eli Lilly

Why Eli Lilly Is Buying Centessa for $7.8 Billion

Why Eli Lilly Is Buying Centessa for $7.8 Billion

Bloomberg Intelligence's Sam Fazeli discusses

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Eli Lilly

Alphabet Names Eli Lilly Executive Ashkenazi as CFO

Alphabet Names Eli Lilly Executive Ashkenazi as CFO

Alphabet Inc. tapped

Nvidia Partners With Eli Lilly on AI Drug Laboratory

Nvidia Partners With Eli Lilly on AI Drug Laboratory

Nvidia plans to invest $1 billion over five years in a new laboratory with

Eli Lilly CFO Lucas Montrace Explains What Drove 56% Year over Year Revenue Beat

Eli Lilly CFO Lucas Montrace Explains What Drove 56% Year over Year Revenue Beat

Eli Lilly

Eli Lilly CFO resigns over 'inappropriate' communication

Eli Lilly CFO resigns over 'inappropriate' communication

Eli Lilly

BofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesity

BofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesity

Geoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to discuss the company's ...

Cramer’s Mad Dash: Eli Lilly

Cramer’s Mad Dash: Eli Lilly

CNBC's Jim Cramer delivers his daily Mad Dash. For access to live and exclusive video from CNBC subscribe to CNBC PRO: ...

Eli Lilly CEO: Deep mistrust with communities of color needs to be addressed

Eli Lilly CEO: Deep mistrust with communities of color needs to be addressed

Eli Lilly

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly CEO David Ricks on Q3 results: The underlying growth story is fantastic

Eli Lilly